BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 38358826)

  • 1. Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signature.
    Mei S; Alchahin AM; Embaie BT; Gavriliuc IM; Verhoeven BM; Zhao T; Li X; Jeffries NE; Pepich A; Sarkar H; Olsen TK; Wickström M; Stenman J; Reina-Bedoya O; Kharchenko PV; Saylor PJ; Johnsen JI; Sykes DB; Kogner P; Baryawno N
    JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38358826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment.
    Garcia-Gerique L; García M; Garrido-Garcia A; Gómez-González S; Torrebadell M; Prada E; Pascual-Pasto G; Muñoz O; Perez-Jaume S; Lemos I; Salvador N; Vila-Ubach M; Doncel-Requena A; Suñol M; Carcaboso AM; Mora J; Lavarino C
    BMC Cancer; 2022 Jun; 22(1):669. PubMed ID: 35715791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature.
    Scaruffi P; Morandi F; Gallo F; Stigliani S; Parodi S; Moretti S; Bonassi S; Fardin P; Garaventa A; Zanazzo G; Pistoia V; Tonini GP; Corrias MV
    Pediatr Blood Cancer; 2012 Jul; 59(1):44-51. PubMed ID: 21994039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium phosphate scaffolds with defined interconnecting channel structure provide a mimetic 3D niche for bone marrow metastasized tumor cell growth.
    Aveic S; Davtalab R; Vogt M; Weber M; Buttler P; Tonini GP; Fischer H
    Acta Biomater; 2019 Apr; 88():527-539. PubMed ID: 30797105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients.
    Yáñez Y; Hervás D; Grau E; Oltra S; Pérez G; Palanca S; Bermúdez M; Márquez C; Cañete A; Castel V
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):573-80. PubMed ID: 26498952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell transcriptomics and epigenomics unravel the role of monocytes in neuroblastoma bone marrow metastasis.
    Fetahu IS; Esser-Skala W; Dnyansagar R; Sindelar S; Rifatbegovic F; Bileck A; Skos L; Bozsaky E; Lazic D; Shaw L; Tötzl M; Tarlungeanu D; Bernkopf M; Rados M; Weninger W; Tomazou EM; Bock C; Gerner C; Ladenstein R; Farlik M; Fortelny N; Taschner-Mandl S
    Nat Commun; 2023 Jun; 14(1):3620. PubMed ID: 37365178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of differentiating neuroblasts in bone marrow is a favorable prognostic factor for bone marrow metastatic neuroblastoma at diagnosis.
    Park SH; Kim S; Park CJ; Jang S; Chi HS; Koh KN; Im HJ; Seo JJ
    Ann Lab Med; 2013 Mar; 33(2):89-96. PubMed ID: 23483759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins.
    Morandi F; Scaruffi P; Gallo F; Stigliani S; Moretti S; Bonassi S; Gambini C; Mazzocco K; Fardin P; Haupt R; Arcamone G; ; Pistoia V; Tonini GP; Corrias MV
    PLoS One; 2012; 7(1):e29922. PubMed ID: 22253825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bone marrow as a metastatic site of human neuroblastoma.
    Morandi F; Corrias MV; Pistoia V
    Ann N Y Acad Sci; 2015 Jan; 1335():23-31. PubMed ID: 25315505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
    Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
    BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR.
    Druy AE; Shorikov EV; Tsaur GA; Popov AM; Zaychikov AN; Tuponogov SN; Saveliev LI; Tytgat GAM; Fechina LG
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27354. PubMed ID: 30007008
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Yogev O; Almeida GS; Barker KT; George SL; Kwok C; Campbell J; Zarowiecki M; Kleftogiannis D; Smith LM; Hallsworth A; Berry P; Möcklinghoff T; Webber HT; Danielson LS; Buttery B; Calton EA; da Costa BM; Poon E; Jamin Y; Lise S; Veal GJ; Sebire N; Robinson SP; Anderson J; Chesler L
    Cancer Res; 2019 Oct; 79(20):5382-5393. PubMed ID: 31405846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.
    Mei S; Alchahin AM; Tsea I; Kfoury Y; Hirz T; Jeffries NE; Zhao T; Xu Y; Zhang H; Sarkar H; Wu S; Subtelny AO; Johnsen JI; Zhang Y; Salari K; Wu CL; Randolph MA; Scadden DT; Dahl DM; Shin J; Kharchenko PV; Saylor PJ; Sykes DB; Baryawno N
    Genome Med; 2024 Jan; 16(1):1. PubMed ID: 38281962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow.
    Hoon DS; Kuo CT; Wen S; Wang H; Metelitsa L; Reynolds CP; Seeger RC
    Am J Pathol; 2001 Aug; 159(2):493-500. PubMed ID: 11485908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Marrow Environment in Metastatic Neuroblastoma.
    Brignole C; Pastorino F; Perri P; Amoroso L; Bensa V; Calarco E; Ponzoni M; Corrias MV
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-metastatic and mesenchymal gene expression signatures characterize circulating tumor cells of neuroblastoma patients with bone marrow metastases and relapse.
    Loh AHP; Angelina C; Wong MK; Tan SH; Sukhatme SA; Yeo T; Lim SB; Lee YT; Soh SY; Leung W; Chang KTE; Chua YW; Alkaff SMF; Lim TKH; Lim CT; Chen ZX
    Front Oncol; 2022; 12():939460. PubMed ID: 36176417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients.
    van Wezel EM; Decarolis B; Stutterheim J; Zappeij-Kannegieter L; Berthold F; Schumacher-Kuckelkorn R; Simon T; Fiocco M; van Noesel MM; Caron HN; van der Schoot CE; Hero B; Tytgat GAM
    Eur J Cancer; 2016 Feb; 54():149-158. PubMed ID: 26796600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
    Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
    Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow metastasis of neuroblastoma analyzed by MRI and its influence on prognosis.
    Tanabe M; Ohnuma N; Iwai J; Yoshida H; Takahashi H; Maie M; Etoh T; Kawamura K
    Med Pediatr Oncol; 1995 May; 24(5):292-9. PubMed ID: 7700180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study.
    Viprey VF; Gregory WM; Corrias MV; Tchirkov A; Swerts K; Vicha A; Dallorso S; Brock P; Luksch R; Valteau-Couanet D; Papadakis V; Laureys G; Pearson AD; Ladenstein R; Burchill SA
    J Clin Oncol; 2014 Apr; 32(10):1074-83. PubMed ID: 24590653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.